CRISPR

CRISPR1-tspan4a

ID
ZDB-CRISPR-200110-3
Name
CRISPR1-tspan4a
Previous Names
None
Target
Sequence
5' - GGATCTCCAGCAGGAAGATCAGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
tsu2cd tspan4a
Expression
Gene expression in Wild Types + CRISPR1-tspan4a
No data available
Phenotype
Phenotype resulting from CRISPR1-tspan4a
No data available
Phenotype of all Fish created by or utilizing CRISPR1-tspan4a
Phenotype Fish Conditions Figures
Kupffer's vesicle decreased size, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 5 from Jiang et al., 2019
determination of pancreatic left/right asymmetry decreased occurrence, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
primordial germ cell spatial pattern, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
forerunner cell group sox17 expression spatial pattern, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 6 from Jiang et al., 2019
intestinal bulb morphology, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
Kupffer's vesicle cilium decreased amount, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 5 from Jiang et al., 2019
pronephric tubule determination of left/right symmetry decreased occurrence, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
determination of liver left/right asymmetry decreased occurrence, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
whole organism migrasome decreased amount, abnormal tspan4atsu2cd/tsu2cd control Fig. 2 from Jiang et al., 2019
liver decreased size, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
determination of digestive tract left/right asymmetry decreased occurrence, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
intestinal bulb decreased size, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
heart decreased size, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
pronephric tubule morphology, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
forerunner cell group distributed, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 6 from Jiang et al., 2019
heart morphology, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
liver morphology, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
forerunner cell group irregular spatial pattern, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 6 from Jiang et al., 2019
determination of intestine left/right asymmetry decreased occurrence, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
determination of heart left/right asymmetry decreased occurrence, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
pronephric tubule decreased size, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
pancreatic bud decreased size, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
pancreatic bud morphology, abnormal tspan4atsu2cd/tsu2cd standard conditions Fig. 3 from Jiang et al., 2019
shield migrasome decreased amount, abnormal tspan4atsu2cd/tsu2cd; s870Tg control Fig. S6 from Jiang et al., 2019
Citations